EUVIMEDEUVIMED entdecken
Crossref

Anti‐Inflammatory and Antidiabetic Metabolites From Mitragyna diversifolia : In Vitro, Phytochemical, and Computational Studies

Jing Lu, Hanlei Wang, Kun Zhang, Xia Zhao, Xuelin Chen, Yuping Chen, Yumei Zhang iD

Chemical Biology & Drug Design · 2026

DOI: 10.1111/cbdd.70234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2026. Verfasst von Jing Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences, Kunming, China. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Anti-Inflammatory Agents, Phytochemicals. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Yunnan Revitalization Talents Support Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitragyna diversifolia is commonly used to cure diarrhoea in the Bandarban region. However, the impact of anti‐inflammatory properties and underlying material basis remains unexplored. This study aimed to determine the anti‐inflammatory and antidiabetic potential of metabolites from M. diversifolia . The results indicated that 2,4‐di‐tert‐bylphenol ( 8 ), cryptotanshinone ( 9 ), and dihydrotanshinone I ( 10 ) not only effectively inhibited LPS‐induced NO production but also demonstrated potential antidiabetic activities by promoting glucose uptake. Network pharmacological analysis, molecular docking, and molecular dynamics simulation revealed that AKT1 was a crucial target for the anti‐inflammatory and antidiabetic effects of M. diversifolia . At the same time, molecular docking analysis showed that compounds 8 , 9 , and 10 possessed superior binding capacities with AKT1 (−7.3, −11.9, and −11.7 kcal/mol, respectively). Collectively, this study preliminarily clarified the possible material basis and mechanism of M. diversifolia to prevent inflammation and diabetes. Further research is needed to determine the in vivo conditions of compounds 8 , 9 , and 10 , particularly with regard to their safety and efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic AgentsAnti-Inflammatory AgentsPhytochemicalsMolecular Docking SimulationAnimalsNitric OxideMiceMolecular Dynamics SimulationLipopolysaccharidesRAW 264.7 CellsProto-Oncogene Proteins c-aktPlant ExtractsGlucose

Stichwörter der Autor:innen

Mitragyna diversifoliaantidiabeticanti‐inflammatorymolecular dockingmolecular dynamics

Substanzen

Hypoglycemic AgentsAnti-Inflammatory AgentsPhytochemicalsNitric OxideLipopolysaccharidesProto-Oncogene Proteins c-aktPlant ExtractsGlucose

Autor:innen und Institutionen

  • Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences, Kunming, China.
  • University of Chinese Academy of Sciences, Beijing, China.

ORCID-Profile: Yumei Zhang

Förderung

  • Yunnan Revitalization Talents Support Plan

Zitieren

APA

Lu, J., Wang, H., Zhang, K., Zhao, X., Chen, X., Chen, Y., & Zhang, Y. (2026). Anti‐Inflammatory and Antidiabetic Metabolites From Mitragyna diversifolia : In Vitro, Phytochemical, and Computational Studies. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70234

Vancouver

Lu J, Wang H, Zhang K, Zhao X, Chen X, Chen Y, et al. Anti‐Inflammatory and Antidiabetic Metabolites From Mitragyna diversifolia : In Vitro, Phytochemical, and Computational Studies. Chemical Biology & Drug Design. 2026. doi:10.1111/cbdd.70234

BibTeX
@article{Lu2026,
  author = {Lu, Jing and Wang, Hanlei and Zhang, Kun and Zhao, Xia and Chen, Xuelin and Chen, Yuping and Zhang, Yumei},
  title = {Anti‐Inflammatory and Antidiabetic Metabolites From Mitragyna diversifolia : In Vitro, Phytochemical, and Computational Studies},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  doi = {10.1111/cbdd.70234}
}
Kostenlos starten →